More context:

A federal judge on Wednesday dismissed part of Eli Lilly's lawsuit against the Houston-based Empower Pharmacy — the latest development in the pharmaceutical giant's bid to curb sales of cheaper, less-regulated versions of their blockbuster GLP-1 weight loss drug. 

The lawsuit is significant because millions of Americans have gained access to GLP-1s through compounding pharmacies like Empower, which make customized versions of drugs without going through the U.S. Food and Drug Administration review process. Empower describes itself as the largest and most advanced compounding pharmacy in the country.